This is a preview of subscription content, log in via an institution to check access.
References
Beale AJ (1981) Cell substrate for killed poliovaccine production. Dev Biol Standard 47, 19-23.
Brands R, Visser J, Medema J, Palache AM and van Scharrenburg GJM (1999) Influvac TC: A safe madin darby canine kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Standard 98, 93-100.
Cinatl Jr J, Cinatl J, Rabenau H, Rapp J, Kornhuber B and Doerr H-W (1993) Protein-free culture of Vero cells: A substrate for replication of human pathogenic viruses. Cell Biol Int 17, 885-895.
Hohenblum H, Naschberger S, Katinger H and Mattanovich D (2000) Production of recombinant human trypsinogen in Escherichia coli and Pichia pastoris-A comparison of expression systems. Presented at the EFB Meeting on Recombinant protein production with prokaryotic and eukaryotic cells. A comparative view on host physiology. Semmering/A, 5.-8.10.2000.
Maurer HR (1986) Towards chemically-defined, serum-free media for mammalian cell culture. In: Freshney RI (ed.) Animal Cell Culture. A Practical Approach (pp. 13-31) IRL Press, Oxford, U.K.
Merten O-W (1999) Cell detachment. In: Spier RE (ed.) Encyclopedia of Cell Technology (pp. 351-365) J. Wiley & Sons, Inc., New York, U.S.A.
Merten O-W, Kallel H, Manuguerra J-C, Tardy-Panit M, Crainic R, Delpeyroux F, van der Werf S and Perrin P (1999) The new medium MDSS2N, free of any animal protein supports growth and production of various viruses. Cytotechnology 30, 191-201.
Merten O-W, Kierulff JV, Castignolles N and Perrin P (1994) Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: Use of various cell lines. Cytotechnology 14, 47-59.
Merten O-W, Wu R, Couvé E and Crainic R (1997) Evaluation of the serum-free medium MDSS2 for the production of poliovirus on Vero cells in bioreactors. Cytotechnology 25, 35-44.
Meslin F-X (1994) Actualité sur la lutte contre la rage humaine et la vaccination antirabique. Cahiers Santé 45, 203-204.
Montagnon BJ, Fanget B and Vincent-Falquet JC (1984) Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect Dis 6, S2, 210-213.
Morgeaux S, Tordo N, Gontier C and Perrin P (1993) Beta-propiolactone treatment impairs tile biological activity of residual DNA from BHK-21 cells infected with rabies virus. Vaccine 11, 82-90. New Century Pharmaceuticals, Inc. http://www.newcenturypharm.com.
Pay TWF, Boge A, Menard FJRR and Radlett PJ (1985) Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process. Dev Biol Standard 60, 171-174.
Perrin P, Madhusudana S, Gontier-Jallet C, Petres S, Tordo N and Merten O-W (1995) An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: Use of serum-free medium and perfusion-reactor system. Vaccine 13, 1244-1250.
Petricciani JC (1987) The liberation of animal cells: Psychology of changing attitudes. In: Spier RE and Griffiths JB (eds) Modern Approaches to Animal Cell Technology (pp. 1-19) Butterworths, Sevenoaks/U.K.
Petricciani JC (1993) Ongoing tragedy of rabies. Lancet 342, 1067.
Radlett PJ, Pay TWF and Garland AJM (1985) The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period. Dev Biol Standard 60, 163-170.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merten, OW. Safety for vaccine(e)s. Cytotechnology 34, 181–183 (2000). https://doi.org/10.1023/A:1008160817560
Issue Date:
DOI: https://doi.org/10.1023/A:1008160817560